CStone Pharmaceuticals Reports 2022 Interim Results and Business Updates
- Written by PR Newswire
SUZHOU, China, Aug. 25, 2022 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today reported 2022 interim financial results and recent business highlights, and leadership...
Read more: CStone Pharmaceuticals Reports 2022 Interim Results and Business Updates














